0917 Synthekine ECP
BioCentury & Getty Images

Emerging Company Profile

Synthekine launches with $82M to create new cytokine signals

Modality-agnostic newco gives cytokines the GPCR treatment for cancer and autoimmunity

Stanford spinout taps structural biology from Chris Garcia’s lab to get new functions from natural cytokine receptors.

Sep 18, 2020 | 1:38 AM GMT

Synthekine is translating the structural biology work of Stanford synthetic cytokine pioneer K. Chris Garcia into a broad platform that could generate

Read the full 720 word article

How to gain access

Continue reading with a
two-week free trial.